A Phase III Intergroup Trial (RTOG 97-04) of Adjuvant Pre- and Post-chemoradiation (CRT) 5-FU vs. Gemcitabine (G) for Resected Pancreatic Adenocarcionma

Carolyn Vachani RN, MSN, AOCN
OncoLink
Ultima Vez Modificado: 18 de noviembre del 2006

Translation for this article does not exist

Blogs

Cancer and Hair Loss
by Bob Riter
February 11, 2016